| Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion L Chicaybam, L Abdo, M Viegas, LVC Marques, P de Sousa, ... Gene Therapy 27 (1), 85-95, 2020 | 36 | 2020 |
| Development of CAR-T cell therapy for B-ALL using a point-of-care approach L de Macedo Abdo, LRC Barros, M Saldanha Viegas, ... Oncoimmunology 9 (1), 1752592, 2020 | 31 | 2020 |
| 4T1 mammary carcinoma colonization of metastatic niches is accelerated by obesity GCM Evangelista, PA Salvador, SMA Soares, LRC Barros, FHDC Xavier, ... Frontiers in Oncology 9, 685, 2019 | 30 | 2019 |
| CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and … L Chicaybam, L Abdo, M Carneiro, B Peixoto, M Viegas, P de Sousa, ... Human gene therapy 30 (4), 511-522, 2019 | 29 | 2019 |
| Immunological-based approaches for cancer therapy L Barros, MA Pretti, L Chicaybam, L Abdo, M Boroni, MH Bonamino Clinics 73, e429s, 2018 | 11 | 2018 |
| Generation of CAR+ T Lymphocytes Using the Sleeping Beauty Transposon System L Chicaybam, L Abdo, MH Bonamino Chimeric Antigen Receptor T Cells: Development and Production, 131-137, 2020 | 8 | 2020 |
| Structural determinants of chimeric antigen receptor design L Abdo, EA Aragão, M Bonamino Critical Reviews™ in Immunology 41 (1), 2021 | 6 | 2021 |
| DEVELOPMENT OF CAR-T CELL THERAPY FOR B-ALL USING A POINT-OF-CARE APPROACH L Abdo, M Viegas, L Marques, P Ferreira, L Barros, L Chicaybam, ... HUMAN GENE THERAPY 30 (12), A4-A5, 2019 | 1 | 2019 |
| In silico and in vivo analysis reveal impact of c-Myc tag in FMC63 scFv-CD19 protein interface and CAR-T cell efficacy AJF Lima, KL Hajdu, L Abdo, LR Batista-Silva, C de Oliveira Andrade, ... Computational and Structural Biotechnology Journal, 2024 | | 2024 |
| Generation of allogeneic 19BBz CAR-T using CRISPRGeneration of allogeneic 19BBz CAR-T using CRISPR EM Correia, LM Abdo, EAA Aragão, C Andrade, SA Reis, LM Vieira, ... Instituto de Tecnologia em Imunobiológicos, 2024 | | 2024 |
| Eficient large-scale point-of-care production of affordable anti-CD19 CAR-T Cells for leukemia immunotherapy LRB Silva, SA Reis, LM Abdo, EAA Aragão, MH Bonamino | | 2024 |
| Avaliação de células CAR-T anti-HER2 em modelo pré-clínico de tumor de ovário EA Aragao, L Abdo, E Correia, LM Vieira, M Bonamino Galoá, 2023 | | 2023 |
| Anti-HER2 CAR-T cells evaluation in a ovarian tumor preclinical model EAA Aragão, LM Abdo, E Mannarino, L Vieira, S Reis, K Hajdu, L Ribeiro, ... | | 2023 |
| Improvement Car-T Cell therapy with ultra-fast protocoland il-15 membrane bound addition LM Abdo, LRC Barros, MS Viegas, LVC Marques, PS Ferreira, E Aragão, ... | | 2023 |
| Evaluation of different transposon-based genetic modification tools for CAR-T cell therapy LM Abdo, E Aragão, K Hajdu, E Mannarino, C Andrade, L Ribeiro, ... | | 2023 |
| Generation of 19bbz CAR-T cells in tcr knockout T-cells EM Correia, C Andrade, LB Silva, B Sessa, LM Abdo, K Hajdu, E Aragão, ... | | 2023 |
| GENERATION AND OPTIMIZATION OF ANTI-CD19 CAR-T CELL FOR LEUKEMIA IMMUNOTHERAPY LRB Silva, L Abdo, M Mazzi, E Aragao, K Hadju, C Andrade, ... Cytotherapy 24 (10), S27-S28, 2022 | | 2022 |
| IN SILICO, IN VITRO, AND IN VIVO EVALUATION OF THE C-MYC TAG INFLUENCE ON AN ANTI-CD19 CAR AJF Lima, LM Abdo, MH Bonamino, MR Lourenzoni Cytotherapy 24 (10), S27, 2022 | | 2022 |
| ANTI-HER2 PIGGYBAC TRANSPOSON-BASED CAR T CELLS PRODUCTION: COMPARISON OF TWO DIFFERENT SCFV CLONES EAA Aragão, LM Abdo, KL Hajdu, LRB Silva, MH Bonamino Cytotherapy 24 (10), S21, 2022 | | 2022 |
| CHARACTERIZATION OF ANTI-CD19 CAR-T CELLS OVEREXPRESSING THE PROTEIN PHF19 GENERATED WITH TRANSPOSON-BASED SYSTEMS KL Hajdu, LRB Silva, LM Abdo, EAA Aragão, MH Bonamino Cytotherapy 24 (10), S2, 2022 | | 2022 |
